FINWIRES · TerminalLIVE
FINWIRES

NewAmsterdam Pharma Says EMA Committee Recommends Approval of Cholesterol Treatments

By

NewAmsterdam Pharma (NAMS) said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization for its cholesterol treatments Ubeslo and Evlarco.

The recommendation was based on phase 3 trial data showing LDL cholesterol reductions of up to 40% with Ubeslo and about 50% with the obicetrapib-ezetimibe combination Evlarco.

The European Commission will review the CHMP opinion and is expected to issue a final decision in the second half of 2026, NewAmsterdam Pharma said.

Shares of NewAmsterdam were up nearly 1% in Friday trading.

Price: $30.81, Change: $+0.26, Percent Change: +0.85%

Related Articles

Wire

Business First Bancshares Q2 Earnings, Revenue Rise; Shares Drop After Hours

Business First Bancshares (BFST) reported core Q2 earnings late Thursday of $0.71 per diluted share, up from $0.66 a year earlier.Analysts polled by FactSet expected $0.70.Revenue in the three months ended June 30, expressed as net interest income plus total other income, rose to $91.8 million from $81.5 million.Four analysts expected $91.3 million.The company's shares fell 3.3% in after-hours trading.

$BFST
Wire

RingCentral Q2 Adjusted Earnings, Revenue Rise; FY Guidance Increases

RingCentral (RNG) reported Q2 non-GAAP net income late Thursday of $1.22 per diluted share, up from $1.06 a year earlier.Analysts polled by FactSet expected $1.16.Revenue in the three months ended June 30 rose to $657 million from $620 million a year earlier.Analysts expected $650.5 million.RingCentral expects Q3 non-GAAP EPS of $1.25 to $1.30 on revenue of $664 million to $670 million.Analysts expect EPS of $1.25 on revenue of $663.2 million.The company raised full-year non-GAAP EPS guidance to the range of $4.96 to $5.10 on revenue of $2.635 billion to $2.646 billion. The previous forecast was EPS of $4.85 to $5.01 on revenue of $2.62 billion to $2.64 billion.Analysts expect EPS of $4.92 on revenue of $2.63 billion.RingCentral shares rose 1.2% in after-hours trading.

$RNG
Wire

Robert Half Q2 Net Income, Revenue Fall; Shares Drop After Hours

Robert Half (RHI) reported Q2 net income late Thursday of $0.26 per share, down from $0.41 a year earlier.Analysts polled by FactSet expected $0.26.Revenue in the three months ended June 30 fell to $1.34 billion from $1.37 billion a year earlier.Analysts expected $1.32 billion.The company's shares fell 5.3% in after-hours trading.

$RHI